A novel compound heterozygous mutation in PYGM gene associated with McArdle's disease.

Acta Myol

Section of Neurology, Department of Biomedicine, Neuroscience, and advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.

Published: March 2022

McArdle's disease is an autosomal recessive glycogenosis due to mutation in the myophosphorylase gene () resulting in a pure myopathy. The clinical onset typically occurs in childhood with cramps, myalgia, and intolerance to physical exercise, although late onset forms are also reported. We describe a case of a 17-year-old male complaining of cramps and myalgia following brief and intense exercise. The patient reported marked improvement in muscle fatigability few minutes after starting aerobic exercise. When he was a child, he had experienced few episodes of vomiting, nausea, and black colored urine following physical activity. Laboratory testings revealed high creatine kinase serum levels. Genetic testings for metabolic myopathies demonstrated a compound heterozygous for two mutations (p.R570Q and p.K754Nfs*49) allowing the diagnosis of McArdle's disease. To date, 183 mutations in the PYGM gene are listed in Human Gene Mutation Database Professional 2021.2, but this novel compound heterozygosis has never been reported before.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004334PMC
http://dx.doi.org/10.36185/2532-1900-067DOI Listing

Publication Analysis

Top Keywords

mcardle's disease
12
novel compound
8
compound heterozygous
8
pygm gene
8
cramps myalgia
8
heterozygous mutation
4
mutation pygm
4
gene
4
gene associated
4
associated mcardle's
4

Similar Publications

Article Synopsis
  • Glycogen Storage Disease type 5 (GSD5), or McArdle disease, is characterized by a lack of glycogen phosphorylase enzyme in muscles, resulting in symptoms such as muscle pain and fatigue during physical activity.
  • The study explored the experiences of 13 individuals with GSD5 through in-depth interviews, analyzing their challenges, diagnosis process, and coping strategies.
  • Four main themes emerged, highlighting major difficulties in daily life, the importance of diagnosis for understanding their condition, management techniques like the ‘second wind’ phenomenon, and the crucial role of support networks for improving life quality.
View Article and Find Full Text PDF

Background: Glycogen storage disease type 5 (McArdle disease) leads to a deficiency in the activity of myophosphorylase resulting in an impaired glucose utilization. The disease can be caused by a variety of mutations in the PYGM gene, and its typical clinical manifestation is muscles weakness within the first three decades of life.

Case Presentation: In this case report we present the diagnostic work-up of a physically active 78-year-old Caucasian patient suffering from a 2-year history of progressive camptocormia including clinical, radiologic, histological, and genetic tests.

View Article and Find Full Text PDF
Article Synopsis
  • Symptoms usually appear in late adolescence or early adulthood, leading to issues like rhabdomyolysis and elevated creatine kinase, with diagnosis confirmed through genetic testing.
  • Treatment involves a diet of slow-absorbing carbohydrates, regular low-intensity exercise, and potentially vitamin B6 and creatine, with a generally favorable prognosis if managed properly, but patients should avoid vigorous exercise to prevent complications.
View Article and Find Full Text PDF

Introduction: Whether cardiac impairment can be fully discarded in McArdle disease-the paradigm of "exercise intolerance," caused by inherited deficiency of the skeletal muscle-specific glycogen phosphorylase isoform ("myophosphorylase")-remains to be determined.

Methods: Eight patients with McArdle disease and seven age/sex-matched controls performed a 15-min moderate, constant-load cycle-ergometer exercise bout followed by a maximal ramp test. Electrocardiographic and two-dimensional transthoracic (for cardiac dimension's assessment) and speckle tracking (for left ventricular global longitudinal strain (GLS) assessments) echocardiographic evaluations were performed at baseline.

View Article and Find Full Text PDF
Article Synopsis
  • Glycogen storage disease type V is linked to mutations in the muscle glycogen phosphorylase gene and is treated with DL-3-hydroxybutyric acid combined with a modified Atkins diet.
  • A 13-year-old girl diagnosed with this disease showed improvements in muscle performance and reduced stiffness in her quadriceps after starting the treatment at age 16.
  • The study highlights the potential of DL-3-hydroxybutyric acid as an alternative energy source, suggesting that further research is necessary to confirm these findings and the utility of shear wave elastography in evaluating treatment outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!